MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

MDT

101.86

+2.58%↑

A

139.37

+1.08%↑

VEEV

224.64

+2.55%↑

HQY

87.09

+3.13%↑

NEOG

9.94

+4.3%↑

Search

Alcon Inc

Open

SectorHealthcare

81.71 0.37

Overview

Share price change

24h

Current

Min

80.88

Max

82.12

Key metrics

By Trading Economics

Income

55M

238M

Sales

18M

2.6B

P/E

Sector Avg

37.619

89.037

Dividend yield

0.42

Profit margin

9.11

Employees

25,000

EBITDA

415M

665M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+15.72% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.42%

2.18%

Next Earnings

24 lut 2026

Market Stats

By TradingEconomics

Market Cap

2.2B

39B

Previous open

81.34

Previous close

81.71

News Sentiment

By Acuity

25%

75%

66 / 360 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

Alcon Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

6 sty 2026, 15:11 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win

9 gru 2025, 18:51 UTC

Acquisitions, Mergers, Takeovers

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9 gru 2025, 15:54 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

Staar Surgical Shares Surge as Alcon Boosts its Buyout Price

9 gru 2025, 14:32 UTC

Acquisitions, Mergers, Takeovers

Alcon Upgrades Offer Price for Staar Surgical

12 lis 2025, 09:09 UTC

Earnings
Major Market Movers

Alcon Shares in Switzerland Climb After Guidance Confirmation

7 sty 2026, 01:00 UTC

Acquisitions, Mergers, Takeovers

Alcon Terminates Agreement To Acquire STAAR Surgical >ALC

6 sty 2026, 22:03 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6 sty 2026, 22:03 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6 sty 2026, 15:21 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Staar May See Management Turnover After Alcon Bid Is Rejected -- Market Talk

6 sty 2026, 14:56 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical Shareholders Reject $1.6B Acquisition by Alcon in Activist Win

6 sty 2026, 14:14 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical: Will Remain a Standalone, Publicly Traded Co and Continue to Trade on Nasdaq >STAA

6 sty 2026, 14:14 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical: No Termination Fee Will Be Payable by Either Party >STAA

6 sty 2026, 14:14 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical: Intend to Terminate Merger Agreement With Alcon >STAA

6 sty 2026, 14:13 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical: Did Not Receive Necessary Stockholder Votes to Approve Merger Agreement With Alcon >STAA

9 gru 2025, 14:17 UTC

Acquisitions, Mergers, Takeovers

Alcon Ups Offer Price for Staar Surgical

9 gru 2025, 13:34 UTC

Acquisitions, Mergers, Takeovers

Alcon: Transaction Now Represents a Total Equity Value of $1.6B >ALC.EB

9 gru 2025, 13:33 UTC

Acquisitions, Mergers, Takeovers

Alcon: Purchase Price Increase Represents an Additional $150M >ALC.EB

9 gru 2025, 13:33 UTC

Acquisitions, Mergers, Takeovers

Alcon: Under the Terms of the Amended Agreement, Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC.EB

9 gru 2025, 13:33 UTC

Acquisitions, Mergers, Takeovers

Alcon To Finance Transaction Through Issuance of Short- and Long-Term Credit Facilities >ALC

9 gru 2025, 13:32 UTC

Acquisitions, Mergers, Takeovers

Alcon: "Go-shop" Window Expired on Dec 6 >ALC.EB

9 gru 2025, 13:32 UTC

Acquisitions, Mergers, Takeovers

Alcon: Transaction Now Represents Total Equity Value of About $1.6B >ALC

9 gru 2025, 13:31 UTC

Acquisitions, Mergers, Takeovers

Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC

9 gru 2025, 13:31 UTC

Acquisitions, Mergers, Takeovers

Alcon Announces Amended Merger Agreement With STAAR Surgical

9 gru 2025, 13:31 UTC

Acquisitions, Mergers, Takeovers

Alcon Enters Amended Merger Agreement for Acquisition of STAAR Surgical >ALC

12 lis 2025, 08:46 UTC

Market Talk

Alcon's Guidance Reiteration Offers Relief -- Market Talk

11 lis 2025, 21:35 UTC

Earnings

Alcon 3Q Adj EPS 79c >ALC

11 lis 2025, 21:35 UTC

Earnings

Alcon 3Q Rev $2.61B >ALC.EB

11 lis 2025, 21:35 UTC

Earnings

Alcon Backs 2025 EPS $3.05-EPS $3.15 >ALC.EB

11 lis 2025, 21:35 UTC

Earnings

Alcon 3Q EPS 48c >ALC.EB

11 lis 2025, 21:34 UTC

Earnings

Alcon Backs 2025 Adj EPS $3.05-Adj EPS $3.15 >ALC

Peer Comparison

Price change

Alcon Inc Forecast

Price Target

By TipRanks

15.72% upside

12 Months Forecast

Average 91.49 USD  15.72%

High 112.534 USD

Low 75.023 USD

Based on 12 Wall Street analysts offering 12 month price targets forAlcon Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

12 ratings

7

Buy

4

Hold

1

Sell

Technical Score

By Trading Central

95.77 / 97.61Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Strong Bullish Evidence

Sentiment

By Acuity

66 / 360 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
help-icon Live chat